Loading...

JBM (Healthcare) Limited

2161.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$2.95
HK$-0.04(-1.34%)

JBM (Healthcare) Limited (2161.HK) Company Profile & Overview

Explore JBM (Healthcare) Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

JBM (Healthcare) Limited (2161.HK) Company Profile & Overview

JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOYat Wai Wong

Contact Information

https://www.jbmhealthcare.com.hk
852 2267 2178
Unit 2303-07, Tower 1, Kwun Tong

Company Facts

279 Employees
IPO DateFeb 5, 2021
CountryHK
Actively Trading

Frequently Asked Questions

;